Professor Declan Murphy

Case Study 1 - Intensification of therapy in metastatic hormone-sensitive prostate cancer (mHSPC): the who, when and how?

Prof Declan Murphy, Consultant Urologist & host of GU Cast, presents a case study regarding de novo mHSPC with fellow GU cast hosts and the expert panel

Language Icon English
duration 6:18
Event topic Icon
Event Icon Video

Job Code : 

AU-ELI-2400057
Prostate Cancer

Prof Declan Murphy

Professor Declan Murphy

Consultant Urologist, Peter MacCallum Cancer Centre

Explaining the benefit of intensification therapy

Intensification of therapy in metastatic hormone-sensitive prostate cancer (mHSPC): the who, when and how?

A/Prof Ben Tran, Medical Oncologist, discusses ‘Explaining the benefit of intensification therapy’ with the GU cast hosts and the expert panel

Language Icon English
duration 7:21
Event topic Icon
Event Icon Video

Job Code : 

AU-ELI-2400055
Prostate Cancer

A/Prof Ben Tran

Associate Professor Ben Tran

Medical Oncologist, Peter MacCallum Department of Oncology

The role of radiation therapy in a patient on ADT + ARPI

Intensification of therapy in metastatic hormone-sensitive prostate cancer (mHSPC): the who, when and how?

A/Prof Amy Hayden, Radiation Oncologist, discusses ‘The role of radiation therapy in a patient on ADT + ARPI’ with the GU cast hosts and the expert panel

Language Icon English
duration 13:52
Event topic Icon
Event Icon Video

Job Code : 

AU-ELI-2400056
Prostate Cancer

A/Prof Amy Hayden

Associate Professor Amy Hayden

Medical Oncologist, Western Sydney Local Health District & GenesisCare

Who to intensify?

Intensification of therapy in metastatic hormone-sensitive prostate cancer (mHSPC): the who, when and how?

A/Prof Ben Tran, Medical Oncologist, discusses ‘Who to intensify?’ with the GU cast hosts and the expert panel 

Language Icon English
duration 3:27 minutes
Event topic Icon
Event Icon Video

Job Code : 

AU-ELI-2400054
Prostate Cancer

A/Prof Ben Tran

Associate Professor Ben Tran

Medical Oncologist, Peter MacCallum Department of Oncology

The puzzle of intensification therapy

Intensification of therapy in metastatic hormone-sensitive prostate cancer (mHSPC): the who, when and how?

Prof Declan Murphy, Consultant Urologist & host of GU Cast, discusses ‘The puzzle of intensification therapy’ with fellow GU cast hosts and the expert panel

Language Icon English
duration 3:52 minutes
Event topic Icon
Event Icon Video

Job Code : 

AU-ELI-2400053
Prostate Cancer

Prof Declan Murphy

Professor Declan Murphy

Consultant Urologist, Peter MacCallum Cancer Centre

Leuprorelin acetate, with Atrigel® delivery system, in the treatment of prostate cancer

Leuprorelin acetate, with Atrigel® delivery system, in the treatment of prostate cancer

International speaker, Prof Axel Merseburger, discusses the efficacy of leuprorelin acetate and the benefits of the Atrigel® delivery system in the treatment of advanced prostate cancer.

Language Icon English
duration 02:09
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300108
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

Locally advanced prostate cancer and neoadjuvant hormone therapy

Locally advanced prostate cancer and neoadjuvant hormone therapy

In this video, international speaker Prof Axel Merseburger, together with local urologist A/Prof Matthew Roberts, discuss neoadjuvant ADT in the treatment of locally advanced prostate cancer.

Language Icon English
duration 05:52
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300105
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

The difference in cardiovascular events between prostate cancer agonists and antagonists

The difference in cardiovascular events between prostate cancer agonists and antagonists

In this video, international speaker Prof Axel Merseburger, together with local urologist A/Prof Matthew Roberts, compare cardiovascular events of agonists and antagonists in the treatment of prostate cancer.

Language Icon English
duration 02:51
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300107
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

ELIGARD® Atrigel® Delivery System

ELIGARD® Atrigel® Delivery System 

Watch the in-depth summary of the Atrigel® delivery system for Eligard® leuprorelin acetate treatment.

Language Icon English
duration 03:43
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300100
Prostate Cancer
Monitoring both PSA and testosterone levels in advanced prostate cancer

Monitoring both PSA and testosterone levels in advanced prostate cancer

Hear from international speaker, Prof Axel Merseburger, as he reviews the importance of monitoring PSA and testosterone levels in advanced prostate cancer and how they correlate with prognosis.

Language Icon English
duration 02:43
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300106
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

Subscribe to Prostate Cancer